Breast Cancer Clinical Trial

Blue Note Therapeutics Product BNT 103 Usability and User Engagement

Summary

This test aims to explore product development-focused usability and user engagement.

View Full Description

Full Description

Sponsor is testing an innovative peer-to-peer communication tool during this trial.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient can read, write, and speak in English
Patient is between the ages of 35-55
Diagnosed with Stage I-III breast cancer
In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
Apple mobile phone or tablet user
Willing to participate in study protocol

Exclusion Criteria:

Any participant not meeting inclusion criteria

Study is for people with:

Breast Cancer

Estimated Enrollment:

15

Study ID:

NCT05032404

Recruitment Status:

Enrolling by invitation

Sponsor:

Blue Note Therapeutics

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Blue Note Therapeutics
San Francisco California, 93065, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

15

Study ID:

NCT05032404

Recruitment Status:

Enrolling by invitation

Sponsor:


Blue Note Therapeutics

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider